Clinical Trials on Multiple Synchronous Lung Cancers (MSLCs) in France

Total 1207 results

Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer (PRIMM)

Patients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients (ProphyloCHIP)

Colorectal Cancer With a Resected Minimal Synchronous PC | Ovarian Metastases | Tumour Rupture in the Abdominal Cavity

France
University Hospital, Toulouse

Recruiting

Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules (KOBE)

Lung Cancer | Lung; Node

France
University Hospital, Grenoble

Completed

Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. (npUBD)

Smoking | Lung Cancer | Radiation Exposure

France
University Hospital, Limoges

Terminated

Evaluation of the Archimedes ™ System for Transparenchymatous Access to Pulmonary Nodules. (SATAN)

Lung Cancer | Bronchoscopy | Solitary Pulmonary Nodule

France
Centre Hospitalier Universitaire, Amiens

Active, not recruiting

Detection and Volumetry of Pulmonary Nodules on Ultra-low Dose Chest CT Scan With Deeplearning Image Reconstruction Algorithm (DLIR) (DLIRTHORAX)

Pulmonary Nodules, Multiple

France
University Hospital, Toulouse

Completed

Quantification of microRNAs in Diagnosis of Pulmonary Nodules (miR-Nod)

Pulmonary Cancer

France
University Hospital, Rouen

Completed

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation (PANEL)

Breast Cancer | Colorectal Cancer | Ovarian Cancer | Pediatric Cancers | Multiple Primary Malignant Tumours

France
Bristol-Myers Squibb

Completed

Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib

Multiple Indications Cancer

France, Poland
Centre Hospitalier Henri Duffaut - Avignon
Institut de Formation en Ostéopathie du Grand Avignon

Terminated

Heart Rate Variability, Vagus Nerve and Cancer

Multiple Myeloma | Colorectal Cancer | Lung Cancer | Non Hodgkin Lymphoma

France
Elsan

Completed

Optimization of the Sensitivity of Histological Diagnosis of Pulmonary Nodules (CRYOPROBE)

Nodule

France
Centre Hospitalier Universitaire de Nice

Completed

Pre-operative Localization of Ground Glass Solitary Pulmonary Nodules (SLIDINGWIRE)

Lung Neoplasms

France
University Hospital, Brest

Recruiting

Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) (PEMBROMIC)

Lung Cancer Stage III | Lung Cancer Stage IV

France
Gustave Roussy, Cancer Campus, Grand Paris
Daiichi Sankyo, Inc.

Recruiting

Datopotamab (DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer (ICARUS-LUNG01)

Metastatic Lung Cancer

France
Assistance Publique Hopitaux De Marseille

Terminated

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Non-small Cell Lung Cancer

France
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Prognostic PET/CT Model in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

France
Centre Henri Becquerel

Recruiting

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment (iTEP1)

Non Small Cell Lung Cancer

France
Centre Henri Becquerel
Intergroupe Francophone de Cancerologie Thoracique

Unknown

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC (RTEP7)

Non-small Cell Lung Cancer

France
Centre Hospitalier Universitaire, Amiens

Unknown

Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy (KBPCT)

Non Small Cells Lung Cancer

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR)

Non-small Cell Lung Cancer

France
Hopital Foch

Terminated

Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response (Immuno-VOC)

Lung Cancer, Non-small Cell

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437)

Non Small Cell Lung Cancer

France
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
University Hospital, Rouen

Completed

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) (EVIEPEB)

Non Small Cell Lung Cancer

France
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer (FENOTYPE)

Metastatic Non-small Cell Lung Cancer

France
University Hospital, Brest

Recruiting

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients With NSCLC (PREDICTION)

Advanced Non Small Cell Lung Cancer

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling) (PIONeeR)

Non-small Cell Lung Cancer Patients

France
Hospices Civils de Lyon

Completed

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

France
University Hospital, Toulouse

Recruiting

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse (MIRACLE)

Non-small Cell Lung Cancer Stage IIIA

France
Poitiers University Hospital

Active, not recruiting

Radiomics for prEdiction of lunG cAncer biologY

Non Small Cell Lung Cancer | Gene Mutation-Related Cancer | PD-L1 | PET/CT

France
Centre Hospitalier Intercommunal Creteil

Completed

Retrospective, Observational, Multi-center Study Evaluating the Efficacy and Tolerance of Brigatinib in the Management of Rearranged CBNPC ROS1 (BRIGAROS)

Lung Cancer ROS Translocated

France
Institut Claudius Regaud
Merck KGaA, Darmstadt, Germany

Completed

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Locally Advanced Non Small Cell Lung Cancer (NSCLC)

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France; Ministère de la Santé et des Solidarités

Recruiting

Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study (CASCADE)

Lung Cancer Screening

France
Institut Claudius Regaud

Terminated

Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer (SPI COHERENCE)

Non Small Cell Lung Cancer | Lung Nodule

France
Centre Paul Strauss

Unknown

Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung Cancer (PNEUMOFRAC)

Stage IA - IB Non Small Cell Lung Cancer

France
Rennes University Hospital
Roche Pharma AG

Completed

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer (ANTiCIPe)

Stage IIIb and IV Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) (TILT)

Lung Cancer | Non Small Cell Lung Cancer

France
Hospices Civils de Lyon

Recruiting

Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells) (LUTON)

Non Small Cell Lung Cancer

France
Hospices Civils de Lyon

Recruiting

CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer (CANPOS)

Non-small Cell Lung Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER

France
Gustave Roussy, Cancer Campus, Grand Paris
Novartis

Unknown

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (RAD001)

Non-small Cell Lung Cancer | Locally Advanced Disease

France
University Hospital, Grenoble

Withdrawn

cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors (LUNG-PREDICT)

Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Molecular Diagnosis of Lung Cancer Via Bronchoscopy: The Significance of Bronchial Liquid Biopsy (ctDNA and ctRNA) (BiliBro)

Non Small Cell Lung Cancer

France
Centre Henri Becquerel

Unknown

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer (RTEP-5)

Stage III Non-small-cell Lung Cancer

France
University Hospital, Limoges

Active, not recruiting

Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer (ExOnSite-Pro)

Lung Cancer | Non Small Cell Lung Cancer | Exosomes

France
Hospices Civils de Lyon

Completed

Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

France
University Hospital, Rouen

Unknown

Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer (LYMPHOLUNG)

Resectable Non-small Lung Cancer

France
Intergroupe Francophone de Cancerologie Thoracique

Completed

A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.

Non-small Cell Lung Cancer | ELDERLY PEOPLE

France
Centre Hospitalier d'Abbeville

Unknown

Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80)

Lung Cancer Screening

France
University Hospital, Lille
Novartis; Santelys Association

Terminated

Early Palliative Care in Metastatic Lung Cancer in Northern France (IMPAQ)

Lung Cancer Metastatic

France

3

Subscribe